IPO

Nidan Laboratories and Healthcare Limited IPO

NSE SME

Listed On: Nov 12, 2021 at ₹ 123.90

₹ 250000 /2000 Shares
*Min Investment

Check Allotment

28 Oct, 2021

Open Date

02 Nov, 2021

Close Date

10 Nov, 2021

Allotment Date

12 Nov, 2021

Listing Date
IPO Issue Details
  • Issue Price ₹125 per equity share
  • Face Value ₹10 Per Equity Share 
  • Issue Price 4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Cr)
  • Listing at NSE SME
  • List Price 123.90
  • Listing Date 2021-11-12
  • Lead Manager First Overseas Capital Limited
  • Registrar Bigshare Services Pvt Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Nidan Laboratories and Healthcare Limited IPO is an SME IPO, priced at ₹125 per equity share. The equity shares have a face value of ₹10 Per Equity Share  each and will be listed on the NSE SME platform.

The IPO bidding window is open from Oct 28, 2021 to Nov 2, 2021. The allotment is expected to be finalized on Nov 10, 2021, and the tentative listing date is Nov 12, 2021.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
3.44x
Total
1.80x
As onQIB / NIIRetailTotal
Shares Offered / Reserved19,00,00019,00,00038,00,000
Day 1 28-10-21 06:00 PM
0.01 x1.13 x0.57 x
Day 2 29-10-21 06:00 PM
0.02 x1.81 x0.91 x
Day 3 01-11-21 06:00 PM
0.14 x2.74 x1.44 x
Day 4 02-11-21 06:00 PM
0.15 x3.44 x1.80 x
Valuations
Earnings Per Share (EPS) ₹1.66/-
P/E Ratio 75.48
RoNW 0.17%
Net Asset Value (NAV) - Post Issue ₹46.34/-
Company Financials
In Crs.
In Cr.
31-Mar-2131-Mar-2031-Mar-19
Assets52.4345.2043.05
Revenue21.8522.1920.97
Profit After Tax2.300.710.22
About Company

Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.

Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.

Read More
- Promoter(s)

Dr. Nithin Vitthalrao Thorave

Pre Issue Share Holding : 99.99%

Post Issue Share Holding : 71.22%

IPO - Issue Objectives
1

Repayment of loans – Rs.16 crores.

2

Additional Working Capital – Rs.26 crores.

3

General Corporate Expenses – Rs.4.4 crores.

4

To meet the expenses of the Issue – Rs.3.6 crores.